Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Company Overview - Avadel Pharmaceuticals plc is a biopharmaceutical company focused on transforming medicines to improve patients' lives [2] - The company has developed LUMRYZ™, the first and only once-at-bedtime oxybate approved by the FDA for treating cataplexy or excessive daytime sleepiness in adults with narcolepsy [2] Upcoming Events - Management will participate in the Leerink Global Biopharma Conference with a fireside chat scheduled for March 11 at 3:20 p.m. ET [1] - The company will also take part in the UBS Virtual CNS Day with a fireside chat on March 18 at 12:30 p.m. ET [1] - Live webcasts and archived recordings of these events will be available on Avadel's Investor Relations website for 90 days following each conference [1]